Celldex Therapeutics
The Director of Inspection Management will lead Celldex's inspection readiness program, coordinating across Quality, Manufacturing, Supply Chain, Regulatory Affairs, and other functions to ensure compliance with global health authority requirements. This role oversees the creation and maintenance of inspection management processes, response handling, CAPA follow‑up, and performance metrics to support the company's transition to a commercial biotechnology organization.
Celldex Therapeutics is a clinical-stage biopharmaceutical company pioneering immunology-based therapies to treat severe inflammatory, allergic, and autoimmune diseases. Their lead program, barzolvolimab, is a humanized monoclonal antibody inhibitor of KIT designed to target mast cells as a core driver of disease. The company leverages deep expertise in antibody-based immunotherapies and proprietary technologies to discover and develop innovative treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Celldex Therapeutics.
10% above the average for this role